van Herpen, C. M. L., Mauer, M. E., Mesia, R., Degardin, M., Jelic, S., Coens, C., . . . Vermorken, J. B. (2010). Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). Nature Publishing Group.
Citação norma Chicagovan Herpen, C M L., et al. Short-term Health-related Quality of Life and Symptom Control With Docetaxel, Cisplatin, 5-fluorouracil and Cisplatin (TPF), 5-fluorouracil (PF) for Induction in Unresectable Locoregionally Advanced Head and Neck Cancer Patients (EORTC 24971/TAX 323). Nature Publishing Group, 2010.
Citação norma MLAvan Herpen, C M L., et al. Short-term Health-related Quality of Life and Symptom Control With Docetaxel, Cisplatin, 5-fluorouracil and Cisplatin (TPF), 5-fluorouracil (PF) for Induction in Unresectable Locoregionally Advanced Head and Neck Cancer Patients (EORTC 24971/TAX 323). Nature Publishing Group, 2010.